Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other physicians.
| NASDAQ: SNTS |
| Current Price: 4.00 |
| Change: 0.00 |
11/23/2009 6:44:36 AM EST
Quotes delayed 20 minutes.
|
|
November 10, 2009
Santarus to Present at Lazard Capital Markets 6th Annual Healthcare Conference
November 4, 2009
Santarus Reports Third Quarter 2009 Financial Results
October 26, 2009
Positive Data from Two Investigator-Initiated Studies with Santarus'' ZEGERID to Be Presented At ACG
|
Santarus is hiring skilled people like you. Join our team today!
